Sagimet was founded in 2006.
Sagimet was incorporated under the laws of the State of Delaware in December 2006 under the name 3-V Biosciences Inc. The company subsequently changed its name to Sagimet Biosciences Inc. in August 2019.
155 Bovet Road, Suite 303
San Mateo, California 94402
You can view our Board of Directors by visiting the "Board of Directors" section of our website.
You can view our management team by visiting the "Senior Management" section of our website.
Deloite & Touche LLP
Sagimet is traded on the NASDAQ Global Market under the symbol “SGMT.”
Sagimet went public on July 14, 2023.
Shares can be purchased through a stockbroker of your choice.
Sagimet does not currently offer a direct stock purchase plan.
Currently, Sagimet does not offer a dividend or a dividend reinvestment program.
Sagimet’s transfer agent is American Stock Transfer & Trust Company, LLC (AST). You can find more information about how to contact AST at:
American Stock Transfer & Trust Company, LLC (AST)
6201 15th Avenue
Brooklyn, NY 11219
If you have misplaced your stock certificates, please contact our transfer agent, AST. There may be a fee involved for replacing lost stock certificates.
You must send both your old and new addresses to our transfer agent, name, address, by U.S. mail. Each stockholder in question must sign a request for an address change.
Quarterly & Annual Reports and other investor materials, when available, can be found in the “Financials & Filings” tab of the “Investors & Media” section of our corporate website. Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov.
You can view our recent press releases by visiting the “News Releases” tab under the “Investors & Media” section of our website.
For media inquiries please send an email to firstname.lastname@example.org.
For investor related questions, please send an email to email@example.com or visit the “Contact IR” tab under the “Resources” tab of the "Investors & Media” section of our website.
Please visit the “Email Alerts” section of our corporate website under the “Resources” tab of the “Investors & Media” section and fill out our web form to be added to our distribution list.